Dupilumab aggravates Sézary syndrome: The importance of accurate pathological diagnosis
Saved in:
Main Authors: | Yoko Homma (Author), Kentaro Yonekura (Author), Yukie Tashiro (Author), Kenjiro Ninomiya (Author), Takuro Kanekura (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dupilumab-associated sezary syndrome
by: Austin Hamp, et al.
Published: (2023) -
A Case of Sézary Syndrome in a Patient Treated with Dupilumab for Atopic Dermatitis
by: Kaito Muramatsu, et al.
Published: (2024) -
Development of mycosis fungoides with peripheral blood involvement after a single use of dupilumab
by: Kazuyasu Fujii, et al.
Published: (2022) -
Alemtuzumab in refractory Sézary syndrome
by: Carmen María Alcántara Reifs, et al.
Published: (2016) -
Therapeutic Efficacy of Etretinate on Cutaneous-type Adult T-cell Leukemia-Lymphoma
by: Kentaro Yonekura, et al.
Published: (2019)